Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the 24th Annual Needham Virtual Growth Conference.
Read More
AngioDynamics, with its disruptive and innovative medical devices, addresses unmet patient needs by elevating the standard of care for chronic and acute disease states in vascular, peripheral vascular, and oncology medicine.
These devices provide healthcare professionals around the world with the vital tools they need to deliver high-quality patient care and improve patient outcomes.
The AlphaVac system is an off the shelf, easy to assemble, emergent mechanical aspiration device, allowing for efficient procedure time…
Today, localized therapy options are limited in providing physicians and patients with a customizable and confident treatment. Most options come…
“The acquisition of Auryon brings a remarkable, foundational technology to our portfolio that will change the way caregivers deliver treatment…
It takes a team of talented people to become one of the world’s leading providers of innovative medical devices.
The deep commitment and contributions of our employees helped to build a global company that’s pioneering new ways to improve patient outcomes.
If you find the idea of joining a dynamic team that’s dedicated to improving the lives of patients appealing, we invite you to review our available opportunities.
.@angiodynamics CEO Jim Clemmer joins @JillMalandrino on @Nasdaq #TradeTalks to discuss cancer and vascular treatment and how Angiodynamics has adapted to the new environment in healthcare delivery. https://twitter.com/i/broadcasts/1vOxwyPNAyWGB
Join @PERTConsortium @BrentKeeling and @JaafGolzar for a discussion led by @JonnyMoriarty on the AlphaVac System, AngioDynamics’ newest mechanical aspiration technology, and the upcoming APEX-AV Study. Register here: https://csavevents.zoom.us/webinar/register/WN_zYKgH_4BQ9K2NBVpFaQ2LA
Risk info: https://bit.ly/AlphaRiskInfo
AngioDynamics thanks skilled and dedicated infusion nurses for their critical role in patient care. We are proud to support you and your patients by making products with care and quality. #INS #IVNurses #IVNursesDay #MedDevice
Thank you to Drs. Powell (IR), Gibber (CT), and Manchec (@Manchec_MD) at @BaptistHealthSF for the livestream at #ISET2022! We thank you for your continued partnership in patient care. @ISETNews #AngioVac
Risk Info: https://bit.ly/AVRiskInfo
AngioDynamics® history is best characterized by innovation and growth. Originally founded in Queensbury, N.Y., U.S., in 1988, AngioDynamics has grown into a NASDAQ-listed public company with a global reach.
Latham, NY (HQ)
Glens Falls, NY (Manufacturing)
Queensbury, NY (Manufacturing)
Marlborough, MA (R&D)
Amsterdam, NL (International HQ)
São Paulo, BR (Brazil Office)
Oakville, CA (Canada Office)
Hong Kong, HK (Asia Pacific Regional Office)
Rehovot, IL (Israel Office)
